Search

everythinglearnresearchcommunity

for

Search:↓

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Nutrafol might help reduce hair loss due to inflammation, but more evidence is needed.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Women with a certain type of hair loss have more copper in the back of their head than the front, and treatment can normalize hair but not copper levels.

Urologists should screen for mental health issues before and during finasteride treatment.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Herbal extracts may help hair grow and could be an alternative to synthetic hair loss treatments.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Finasteride may improve stem cell therapy for heart attacks by increasing cell survival.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Minoxidil 2% is more effective for female hair loss, but botanicals have fewer side effects.

Oral minoxidil is effective for various hair loss types and may improve male sexual function, but aspirin can reduce its effectiveness.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Some treatments like topical oxygen and stem cells show promise for wound healing and hair growth, but evidence for modern dressings over traditional ones is limited.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.